Your browser doesn't support javascript.
loading
Distinct blood transcriptomic signature of treatment in latent tuberculosis infected individuals at risk of developing active disease.
Burel, Julie G; Singhania, Akul; Dubelko, Paige; Muller, Julius; Tanner, Rachel; Parizotto, Eneida; Dedicoat, Martin; Fletcher, Thomas E; Dunbar, James; Cunningham, Adam F; Lindestam Arlehamn, Cecilia S; Catanzaro, Donald G; Catanzaro, Antonino; Rodwell, Timothy; McShane, Helen; O'Shea, Matthew K; Peters, Bjoern.
Afiliação
  • Burel JG; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Singhania A; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Dubelko P; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Muller J; The Jenner Institute, University of Oxford, Oxford, UK.
  • Tanner R; The Jenner Institute, University of Oxford, Oxford, UK.
  • Parizotto E; The Jenner Institute, University of Oxford, Oxford, UK.
  • Dedicoat M; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
  • Fletcher TE; Royal Centre for Defence Medicine, Joint Medical Command, Birmingham, UK; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, UK.
  • Dunbar J; Department of Infectious Diseases, The Friarage Hospital, Northallerton, UK.
  • Cunningham AF; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
  • Lindestam Arlehamn CS; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Catanzaro DG; University of Arkansas, Fayetteville, AR, USA.
  • Catanzaro A; Department of Medicine, University of California San Diego, CA, USA.
  • Rodwell T; Department of Medicine, University of California San Diego, CA, USA.
  • McShane H; The Jenner Institute, University of Oxford, Oxford, UK.
  • O'Shea MK; University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK; Royal Centre for Defence Medicine, Joint Medical Command, Birmingham, UK; Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK. Electronic address: M.K.OSHEA@bham.ac.uk.
  • Peters B; Vaccine Discovery Division, La Jolla Institute for Immunology, La Jolla, CA, USA; Department of Medicine, University of California San Diego, CA, USA. Electronic address: bpeters@lji.org.
Tuberculosis (Edinb) ; 131: 102127, 2021 12.
Article em En | MEDLINE | ID: mdl-34555657
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Latente / Transcriptoma / Mycobacterium tuberculosis Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Tuberculose Latente / Transcriptoma / Mycobacterium tuberculosis Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Limite: Adult / Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2021 Tipo de documento: Article